|
1
|
Schreiber RD, Old LJ and Smyth MJ: Cancer
immunoediting: Integrating immunity's roles in cancer suppression
and promotion. Science. 331:1565–1570. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim R, Emi M and Tanabe K: Cancer
immunoediting from immune surveillance to immune escape.
Immunology. 121:1–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rah YC, Ahn JC, Jeon EH, Kim H, Paik JH,
Jeong WJ, Kwon SY and Ahn SH: Low expression of CD40L in tumor-free
lymph node of oral cavity cancer related with poor prognosis. Int J
Clin Oncol. 23:851–859. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee CH, Lee SJ, Choi SH, Ahn SH, Son BH,
Lee JW, Yu JH, Kwon NJ, Lee WC, Yang KS, et al: Cancer panel
analysis of circulating tumor cells in patients with breast cancer.
Oncol Lett. 16:612–618. 2018.PubMed/NCBI
|
|
5
|
Ahn SH, Choi JY, Kim DW, Lee DY, Jeon EH,
Jeong WJ and Paik JH: Targeting HIF1α peri-operatively increased
post-surgery survival in a tongue cancer animal model. Ann Surg
Oncol. 22:3041–3048. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Basel MT, Narayanan S, Ganta C, Shreshta
TB, Marquez A, Pyle M, Hill J, Bossmann SH and Troyer DL:
Developing a xenograft human tumor model in immunocompetent mice.
Cancer Lett. 412:256–263. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Buller RM, Holmes KL, Hügin A,
Frederickson TN and Morse HC III: Induction of cytotoxic T-cell
responses in vivo in the absence of CD4 helper cells. Nature.
328:77–79. 1987. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ghosh S, Sarkar M, Ghosh T, Guha I,
Bhuniya A, Biswas J, Mallick A, Bose A and Baral R: Absence of
CD4(+) T cell help generates corrupt CD8(+) effector T cells in
sarcoma-bearing Swiss mice treated with NLGP vaccine. Immunol Lett.
175:31–39. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rigo V, Emionite L, Daga A, Astigiano S,
Corrias MV, Quintarelli C, Locatelli F, Ferrini S and Croce M:
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies
cures syngeneic disseminated neuroblastoma. Sci Rep. 7:140492017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Graham BS and Wetherall NT: Growth of
human cell lines in BALB/c mice. Cancer Res. 50:5943–5946.
1990.PubMed/NCBI
|
|
11
|
Ku JL, Kim WH, Lee JH, Park HS, Kim KH,
Sung MW and Park JG: Establishment and characterization of human
laryngeal squamous cell carcinoma cell lines. Laryngoscope.
109:976–982. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cavalieri S, Rivoltini L, Bergamini C,
Locati LD, Licitra L and Bossi P: Immuno-oncology in head and neck
squamous cell cancers: News from clinical trials, emerging
predictive factors and unmet needs. Cancer Treat Rev. 65:78–86.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hassan SB, Sørensen JF, Olsen BN and
Pedersen AE: Anti-CD40-mediated cancer immunotherapy: An update of
recent and ongoing clinical trials. Immunopharmacol Immunotoxicol.
36:96–104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu SY and Wu YL: Ongoing clinical trials
of PD-1 and PD-L1 inhibitors for lung cancer in China. J Hematol
Oncol. 10:1362017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kuilman T, Michaloglou C, Vredeveld LC,
Douma S, van Doorn R, Desmet CJ, Aarden LA, Mooi WJ and Peeper DS:
Oncogene-induced senescence relayed by an interleukin-dependent
inflammatory network. Cell. 133:1019–1031. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ostroumov D, Fekete-Drimusz N, Saborowski
M, Kühnel F and Woller N: CD4 and CD8 T lymphocyte interplay in
controlling tumor growth. Cell Mol Life Sci. 75:689–713. 2018.
View Article : Google Scholar : PubMed/NCBI
|
